LMR Partners LLP Invests $3.66 Million in CME Group Inc. (CME)
LMR Partners LLP bought a new stake in shares of CME Group Inc. (NASDAQ:CME) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 29,219 shares of the financial services provider’s stock, valued at approximately $3,659,000.
Other hedge funds have also recently bought and sold shares of the company. Highland Capital Management LLC acquired a new position in CME Group during the first quarter valued at about $273,000. Bank of Montreal Can boosted its position in CME Group by 7.0% in the first quarter. Bank of Montreal Can now owns 352,984 shares of the financial services provider’s stock valued at $41,934,000 after buying an additional 23,242 shares during the last quarter. CrestPoint Capital Management LLC acquired a new position in CME Group during the first quarter valued at about $202,000. Atria Investments LLC boosted its position in CME Group by 4.1% in the first quarter. Atria Investments LLC now owns 2,315 shares of the financial services provider’s stock valued at $275,000 after buying an additional 91 shares during the last quarter. Finally, Skylands Capital LLC boosted its position in CME Group by 24.9% in the first quarter. Skylands Capital LLC now owns 22,800 shares of the financial services provider’s stock valued at $2,709,000 after buying an additional 4,550 shares during the last quarter. 83.25% of the stock is owned by institutional investors and hedge funds.
Shares of CME Group Inc. (NASDAQ:CME) opened at 124.68 on Tuesday. The firm has a market capitalization of $42.38 billion, a P/E ratio of 25.45 and a beta of 0.73. The stock’s 50 day moving average price is $123.43 and its 200-day moving average price is $121.02. CME Group Inc. has a 12-month low of $98.95 and a 12-month high of $127.96.
CME Group (NASDAQ:CME) last announced its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, topping the consensus estimate of $1.20 by $0.03. The firm had revenue of $925 million for the quarter, compared to the consensus estimate of $931.05 million. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The business’s quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.14 EPS. On average, equities analysts expect that CME Group Inc. will post $4.81 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Friday, September 8th will be issued a dividend of $0.66 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.64 annualized dividend and a dividend yield of 2.12%. CME Group’s payout ratio is 53.99%.
Several equities research analysts have recently commented on the company. BidaskClub lowered CME Group from a “hold” rating to a “sell” rating in a research note on Friday, July 28th. Royal Bank Of Canada boosted their price target on CME Group from $130.00 to $135.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 20th. Jefferies Group LLC reissued a “buy” rating and set a $134.00 price target (up previously from $128.00) on shares of CME Group in a research note on Monday, July 17th. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating in a research note on Tuesday, July 11th. Finally, UBS AG reissued a “buy” rating and set a $134.00 price target (down previously from $136.00) on shares of CME Group in a research note on Monday, June 5th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $131.63.
In related news, insider Derek Sammann sold 2,100 shares of the company’s stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $117.86, for a total value of $247,506.00. Following the sale, the insider now owns 31,026 shares of the company’s stock, valued at $3,656,724.36. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, President Bryan T. Durkin sold 9,200 shares of the company’s stock in a transaction dated Tuesday, August 8th. The shares were sold at an average price of $125.13, for a total transaction of $1,151,196.00. Following the completion of the sale, the president now directly owns 70,938 shares in the company, valued at approximately $8,876,471.94. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 91,085 shares of company stock worth $11,242,896. Insiders own 0.61% of the company’s stock.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.